Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Drew A, Wells"'
Autor:
Miguel Rodriguez, Christian Sidebottom, Drew A. Wells, Thirumalaivasan Dhasakeerthi, Lisa Hayes, Cheran Elangovan, Balaji Krishnaiah
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 4, Iss 4 (2024)
Alteplase, a biosynthetic form of human tissue‐type plasminogen activator, is Food and Drug Administration‐approved for the treatment of acute ischemic stroke and currently the standard of care for thrombolytic therapy. Tenecteplase, a modified f
Externí odkaz:
https://doaj.org/article/615a61c1954841a9b373a13cf28c65b6
Publikováno v:
Clinical Nephrology. 98:147-154
Gabapentinoids (GPs) are frequently prescribed in individuals with chronic kidney disease (CKD); however, their exclusive renal elimination warrants dose adjustments to decrease risk of toxicity. This study evaluated GP prescribing patterns and wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f07d3101a4f0c7344c5e8b43fe9dbd08
https://doi.org/10.5414/cn110815
https://doi.org/10.5414/cn110815
Publikováno v:
The Annals of pharmacotherapy.
Objective: To provide an overview of clinical sequelae and emerging treatment options for hemophagocytic lymphohistiocytosis (HLH). Data Sources: A literature search was conducted using the search terms “hemophagocytic lymphohistiocytosis,” “he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fc2eb75cc31fbde5edae8482f16793
https://pubmed.ncbi.nlm.nih.gov/36349896
https://pubmed.ncbi.nlm.nih.gov/36349896
Autor:
Drew A Wells, Asia J Johnson, Jack G Lukas, Diana A Hobbs, Kerry O Cleveland, Jennifer D Twilla, Athena L V Hobbs
Publikováno v:
JAC-antimicrobial resistance. 5(1)
Objectives Carbapenems are appealing agents for empirical use given their broad spectrum of activity; however, selective use is vital in minimizing the risk for development of carbapenem-resistant pathogens. We aimed to examine the impact of carbapen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ac9c6072cdffcf497f48c5f323de00
https://pubmed.ncbi.nlm.nih.gov/36601545
https://pubmed.ncbi.nlm.nih.gov/36601545
Publikováno v:
Hospital Pharmacy. :001857872311518
Background: Ceftriaxone is a commonly utilized antibiotic for the treatment of urinary tract infections (UTI) despite the limited literature supporting its use. Opportunities for antimicrobial stewardship (ASP), including IV-to-PO conversions and de-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfb4a9dfaa9734756cd2b004710c8758
https://doi.org/10.1177/00185787231151864
https://doi.org/10.1177/00185787231151864
Autor:
Drew A. Wells, Lyndsey K. Davis, Omar Saeed, G. Morgan Jones, Cheran Elangovan, Andrei V. Alexandrov, Balaji Krishnaiah, Katherine L. March
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 31:106868
Alteplase, a tissue-type plasminogen activator, is recommended for ischemic stroke patients presenting within 4.5 h. Due to bleeding risks, current guidelines advise delaying antiplatelet therapy for 24 h after alteplase. However, specific scenarios
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f11a59ad9b92f1b3e05efc9e9d4b56
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106868
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106868